Press release
Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment Industry Trends Gaining Momentum in the Global Follicle Stimulating Hormone Market
Follicle Stimulating Hormone
Follicle Stimulating Hormone Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for the follicle stimulating hormone (FSH) has seen robust growth in the recent past. It's projected to expand from $2.03 billion in 2024, increasing to $2.14 billion by 2025, at a compound annual growth rate (CAGR) of 5.4%. The significant growth during the historical interval is credited to the surge in hormonal disorder cases, rising need for fertility treatments, widened application scope of FSH, introduction of new FSH products into the market, and an escalating demand for reliable and efficient contraceptive choices.
Follicle Stimulating Hormone Market Size Forecast: What's the Projected Valuation by 2029?
The market size of the follicle stimulating hormone is predicted to experience substantial growth in the coming years, reaching $2.64 billion in 2029 with a 5.4% compound annual growth rate (CAGR). This forecasted growth in the market can be linked to an increase in therapeutic applications, demand for therapy combinations, the need for efficient contraceptive options, healthcare needs due to an aging population, and market growth in critical regions. The up and coming trends for this period consist of advanced biosimilar FSH products, regulatory green lights and market accessibility, improvements in FSH production and deliverance, and an escalating need for viable contraceptive options.
View the full report here:
https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report
What Are the Drivers Transforming the Follicle Stimulating Hormone Market?
The rise in infertility rates is anticipated to fuel expansion of the follicle-stimulating hormone industry. Infertility, a condition impacting the reproductive system of either gender, is characterized by an inability to happen upon conception after a year or more of regular unprotected intercourse. The follicle-stimulating hormone fosters egg growth in the ovaries and helps control the menstrual cycle in women. It also boosts testicular enlargement in men and facilitates the production of a critical protein for male fertility through encouraging the formation of healthy sperm cells. For instance, the World Health Organization, a specialist agency of the United Nations based in Switzerland, indicated in April 2023 that approximately one in every six adults globally, or around 17.5% of the adult populace, were affected by infertility. Moreover, the Australian Bureau of Statistics, an independent constitutional organization in Australia responsible for data collection and analysis to inform government policy, reported that there were 300,684 documented births in 2022, marking a 3% decrease from 2021. The overall fertility rate for Australian women stood at 1.63 births per woman. Consequently, the escalating rates of infertility are contributing to the growth of the follicle-stimulating hormone market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp
What Long-Term Trends Will Define the Future of the Follicle Stimulating Hormone Market?
The emergence of product innovations is a leading trend observed in the follicle-stimulating hormone market. Key industry players in this market are intensifying efforts to develop novel products to bolster their market stance. Highlighting this trend, in July 2024, Proov, a women's health company from the US, introduced the Proov Empower Perimenopause Testing System. This system provides extensive and tailored knowledge about how a woman's fluctuating hormones impact her overall health and well-being. The Proov Empower conducts a user-friendly, multiple-point urine test to assess four principal hormones-FSH, E1G (an estrogen marker), PdG (a progesterone marker), and LH-that regulate symptoms and the perimenopause journey. By offering regular retesting, this system helps women monitor their hormone changes and symptoms, acting as an essential guide on their journey towards menopause.
Which Segments in the Follicle Stimulating Hormone Market Offer the Most Profit Potential?
The follicle stimulating hormone market covered in this report is segmented -
1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users
Subsegments:
1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations
2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12486&type=smp
Which Firms Dominate the Follicle Stimulating Hormone Market by Market Share and Revenue in 2025?
Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.
Which Regions Offer the Highest Growth Potential in the Follicle Stimulating Hormone Market?
North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12486
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment Industry Trends Gaining Momentum in the Global Follicle Stimulating Hormone Market here
News-ID: 4099084 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for FSH
Follicle Stimulating Hormone (FSH) ELISA Test Kit Market Key Players, Share and …
"The global market for Follicle Stimulating Hormone (FSH) ELISA test kits is valued at approximately $260 million in 2024. This sector is projected to experience significant growth, with an estimated market value reaching around $430 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 5.2% from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "Follicle Stimulating Hormone (FSH) ELISA Test Kit Market". This report…
Follicle-Stimulating Hormone (FSH) Market 2022 - 2030: Rising Demand for Inferti …
Follicle-stimulating hormone (FSH) is a hormone that plays a crucial role in regulating the menstrual cycle and reproductive system in women. The increasing incidence of infertility, changing lifestyle patterns, and the growing number of women opting for assisted reproductive techniques are driving the growth of the FSH market. In addition, the rising awareness about infertility treatments, increasing disposable income, and the growing number of infertility clinics and hospitals are also…
Veterinary Follicle Stimulating Hormones (FSH) Market Booming Worldwide( Forecas …
The global Veterinary Follicle Stimulating Hormones (FSH) market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Veterinary Follicle Stimulating Hormones (FSH) market. For instance, the market dynamics section digs deep into the drivers, restraints,…
Global Veterinary Follicle Stimulating Hormones (FSH) Market Size,Share, Analysi …
Los Angeles, United States November 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Veterinary Follicle Stimulating Hormones (FSH) market. It sheds light on how the global Veterinary Follicle Stimulating Hormones (FSH) market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the…
Global Follicle Stimulating Hormone (FSH) Market Top Leading Players with Strate …
The global follicle stimulating hormone (FSH) market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). The gonadotropic hormone is secreted by the anterior pituitary gland. It supports in the development of pubertal maturation and the reproductive process. The major factor expected to drive the market is increasing adoption of assisted reproductive technology (ART) and the rising number of infertility patients seeking treatment. Moreover, hypothalamic…
Follicle-stimulating Hormone (FSH) Market : New Business Opportunities and Inves …
In 2017, the global Follicle-stimulating Hormone (FSH) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Follicle-stimulating Hormone (FSH) market based on company, product type, application and key regions.
This report studies the global market size of Follicle-stimulating Hormone (FSH) in key regions like North…
